Investors
Information

Visit your VStock shareholder account here:

INVESTOR RELATIONS FAQ’s

Ainnova Tech a Nevada Company was founded in 2020 in San Jose, Costa Rica where it is Headquartered and have current offices in Mexico City, Mexico and Houston, Texas. We are a health tech start up founded by an experienced and innovative team to create solutions for early detection of diseases using artificial intelligence. We have achieved multiple global awards, signed partnerships with hospitals and a globally recognized medical device Company. Now, we are launching VisionAi, our platform to prevent blindness and detection of early onset of diabetes

Ainnova Tech is a private company with the full intent to be public in 2025. No stock symbol has been issued.

Investors can invest directly in the company but be an Accredited Investor, You can find out more by simply emailing investors@ainnovatech.com

Currently, Ainnova Tech does not pay a dividend on its common stock.

Public Accounting firm:
Solis Intl Consultants LLC

Website: https://solisinternational.com/
Phone: (832) 295 0156

Email: info@solisinternational.com

25420 Kuykendahl Rd. Suite B-100 Tomball, 77375, Texas, USA 

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598

Phone: 212.828.8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179
Email: info@vstocktransfer.com 

Questions regarding stock holdings, certificate replacement/transfer, dividends and address changes should be directed to our Transfer Agent listed above

Veritas Consulting Group Inc
30 Wall Street, 8Th Floor, New York, New York 10005
Phone: 212-709-8334 

You can submit a question directly to The Ainnova Tech Investor Relations team by emailing investors@ainnovatech.com or by getting a hold of Veritas Consulting Group at 212-709-8334 .

You can submit a question to The Ainnova Tech Public Relations team at pr@ainnovatech.com

In San Jose, Costa Rica and have current offices in both Mexico City, Mexico and Houston, Texas

All reports, as well as other SEC filings, can be viewed directly on the SEC Website at www.sec.gov

Disclaimer: This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent official corporate documents on file with the U.S. Securities and Exchange Commission. The statements that are not historical facts contained in releases or in our posted events and presentations are forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company’s Securities and Exchange Commission filings. AINNOVA TECH, Inc. does not undertake any obligation to update forward-looking statements after the date of such releases except to the extent required under applicable federal and state securities laws. This website contains links to websites maintained by other companies. Ainnova Tech is providing these links to readers only as a convenience. The inclusion of any link does not imply that Ainnova Tech endorses any third-party website or third-party company or product. Ainnova Tech does not have any control over the content of such third-party websites and assumes no responsibility whatsoever for the functionality of such websites or for the accuracy of any information presented at such other websites.

Contact Us

Houston

44 Lousiana St, Lyric Tower
Houston, Texas, 77002
+1 (713) 714 0779

Costa Rica

Plaza Roble Corporate Center
Escazú, San José
+506 2201 1486

México

Mazaryk 111, Piso 1
Polanco, Ciudad de México
+52 55 88741865

Ainnova Tech © Copyright 2024.  All Rights Reserved.